Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | hydralazine | 5365247 | drug-path |
| Chemokine signaling pathway | R-HSA-168638 | map04062 | hydralazine | 5365247 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | hydralazine | 5365247 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | hydralazine | 5365247 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | 6-benzylaminopurine | 4170 | drug-path |
| Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | 6-benzylaminopurine | 4170 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | 6-benzylaminopurine | 4170 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | 6-benzylaminopurine | 4170 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | 6-benzylaminopurine | 4170 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | 6-benzylaminopurine | 4170 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | 6-benzylaminopurine | 4170 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | 6-benzylaminopurine | 4170 | drug-path |
| Asthma | R-HSA-444620 | map05310 | 6-benzylaminopurine | 4170 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | 6-benzylaminopurine | 4170 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | 6-benzylaminopurine | 4170 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | 6-benzylaminopurine | 4170 | drug-path |
| Melanogenesis | R-HSA-5662702 | map04916 | 6-benzylaminopurine | 4170 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | 6-benzylaminopurine | 4170 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | 6-benzylaminopurine | 4170 | drug-path |
| Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | tropicamide | 5593 | drug-path |